Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

17.1K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.1K
Inflammation01:38

Inflammation

62.6K
Overview
62.6K
Complement System01:27

Complement System

11.1K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.9K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

28
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
28
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

25
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Current knowledge and challenges of sepsis-associated encephalopathy.

Intensive care medicine·2026
Same author

Systemic corticosteroids for severe community-acquired pneumonia: a narrative review of mechanisms and critical appraisal of recent trials in ICU.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Assessment of differences in immune responses to albumin compared with crystalloids for resuscitation in sepsis.

Critical care (London, England)·2026
Same author

Current knowledge and challenges of sepsis-associated encephalopathy.

Intensive care medicine·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

JCO clinical cancer informatics·2026

Related Experiment Video

Updated: Feb 18, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.5K

Immune Activation in Sepsis.

Andrew Conway-Morris1, Julie Wilson2, Manu Shankar-Hari2

  • 1Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 93, Cambridge CB2 0QQ, UK; John V Farman Intensive Care Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.

Critical Care Clinics
|November 19, 2017
PubMed
Summary
This summary is machine-generated.

Sepsis results from a dysregulated immune response to infection, leading to multisystem effects and organ dysfunction. Understanding how protective immunity becomes harmful is key to treating this condition.

Keywords:
ImmunosuppressionInflammationSepsis

More Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.6K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

554

Related Experiment Videos

Last Updated: Feb 18, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.5K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.6K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

554

Area of Science:

  • Immunology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Sepsis is a life-threatening condition characterized by a dysregulated host response to infection.
  • The immune system's protective mechanisms, including pathogen recognition and effector functions, are crucial for combating infection.
  • Impaired organ function distant from the infection site is a hallmark of sepsis.

Purpose of the Study:

  • To elucidate the complex immune mechanisms underlying sepsis.
  • To understand the transition from a protective immune response to a maladaptive one in sepsis.
  • To identify key molecular patterns that trigger sepsis-related immune activation.

Main Methods:

  • Review of current literature on sepsis pathophysiology.
  • Analysis of immune cell activation pathways in response to infection.
  • Examination of molecular pattern recognition in sepsis.

Main Results:

  • Immune activation in sepsis involves pathogen-associated and host-derived molecular patterns.
  • Detection of these patterns initiates multisystemic inflammatory responses.
  • The precise mechanisms driving the shift from adaptive to maladaptive immunity in sepsis are not fully understood.

Conclusions:

  • Sepsis involves a complex interplay of immune responses to infection.
  • Further research is needed to clarify the transition to dysregulated immunity in sepsis.
  • Understanding these processes is critical for developing effective sepsis therapies.